Tech & Innovation

Insilico and Therasid Collaborate to Advance AI-Driven MASH Treatments
Tech & Innovation Insilico and Therasid Collaborate to Advance AI-Driven MASH Treatments

In the rapidly evolving landscape of biotechnology, the merger of artificial intelligence and drug discovery continues to unlock groundbreaking advances in medical treatments. The latest collaboration between Insilico Medicine and Therasid Bioscience highlights the transformative potential of

Can Gene Therapy DB-OTO Revolutionize Treatment for Genetic Hearing Loss?
Tech & Innovation Can Gene Therapy DB-OTO Revolutionize Treatment for Genetic Hearing Loss?

In this interview, we are pleased to welcome Ivan Kairatov, a Biopharma expert with deep knowledge of tech and innovation in the industry and extensive experience in research and development, particularly in gene therapy for sensory disorders. Today, Ivan will share insights on the recent positive

Can PREFUL MRI Revolutionize Long COVID Diagnosis in Children?
Tech & Innovation Can PREFUL MRI Revolutionize Long COVID Diagnosis in Children?

Ivan Kairatov is a biopharma expert with extensive knowledge of technology and innovation in the industry. He has significant experience in research and development and is here to discuss recent findings about lung abnormalities in children and adolescents with long COVID. What is long COVID, and

Can Telehealth and PCPs Revolutionize Advanced Diabetes Care Access?
Tech & Innovation Can Telehealth and PCPs Revolutionize Advanced Diabetes Care Access?

Ivan Kairatov is a Biopharma expert, with profound knowledge in technology and innovation in the medical industry, and extensive experience in research and development. Today, we'll delve into a study from the University of Colorado Anschutz Medical Campus, discussing its significance for

Can AI in Health Care Reduce Bias or Worsen Disparities?
Tech & Innovation Can AI in Health Care Reduce Bias or Worsen Disparities?

The transformative impact of AI-based algorithms on the health care industry offers both immense potential for improving medical outcomes and significant challenges related to bias and disparities. The unexpected discovery by radiologist Judy Gichoya, M.D., and her team that AI could predict a

FDA Approves Ctexli for Rare Genetic Disorder Cerebrotendinous Xanthomatosis
Tech & Innovation FDA Approves Ctexli for Rare Genetic Disorder Cerebrotendinous Xanthomatosis

Mirum Pharmaceuticals recently made headlines as they secured FDA approval for Ctexli, also known as chenodiol, as the first treatment for cerebrotendinous xanthomatosis (CTX). CTX, a rare genetic lipid storage disease, affects an estimated 3 to 5 individuals per 100,000. This approval came after a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later